title: Kupffer cell-derived prostaglandin E2 is involved in regulation of lipid synthesis in rat liver tissue.
abstract: Our recent studies suggest that Kupffer cells play a role in the physiological regulation of lipid metabolism of the adjacent hepatocytes. In the present study, we have tested the hypothesis that inhibition of Kupffer cells decreases prostaglandin E(2) (PGE(2)) release inside liver tissue, a phenomenon contributing to lipid accumulation in hepatocytes. PGE(2) secretion as well as lipid synthesis were assessed in precision-cut liver slices (PCLS) from rats previously treated with Kupffer cell inhibitors (GdCl(3) 10 mg kg(-1) body wt, i.v. injection and glycine 5% in diet). In addition, lipid synthesis was assessed in primary rat hepatocytes cultured in the absence or presence of PGE(2) (0.01, 1 and 10 microM). Inhibition of Kupffer cell activity by GdCl(3) decreases PGE(2) secretion by PCLS and resulted in a higher lipid synthesis. Since incubation with PGE(2) over 48 h decreases lipid synthesis from acetate in cultured hepatocytes, we propose that the lower PGE(2) secretion linked to Kupffer cell inhibition, partly explains a higher rate of synthesis of lipids with a subsequent accumulation in liver tissue, as previously shown in fasted rats.
authors.affiliation: Unité de Pharmacocinétique, Métabolisme, Nutrition et Toxicologie, Département des Sciences Pharmaceutiques, Université Catholique de Louvain, B-1200 Brussels, Belgium.
authors.forename: Audrey M
authors.initials: AM
authors.lastname: Neyrinck
authors.forename: Sabrina
authors.initials: S
authors.lastname: Margagliotti
authors.forename: Cristina
authors.initials: C
authors.lastname: Gomez
authors.forename: Nathalie M
authors.initials: NM
authors.lastname: Delzenne
mesh_terms: D000085:Acetates / Q000378:metabolism; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D002478:Cells, Cultured; D002784:Cholesterol / Q000096:biosynthesis / Q000378:metabolism; D015232:Dinoprostone / Q000378:metabolism / Q000494:pharmacology / Q000502:physiology*; D005682:Gadolinium / Q000494:pharmacology; D005998:Glycine / Q000494:pharmacology; D022781:Hepatocytes / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D007657:Ketone Bodies / Q000096:biosynthesis; D007728:Kupffer Cells / Q000187:drug effects / Q000378:metabolism*; D008055:Lipids / Q000096:biosynthesis*; D008099:Liver / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D019308:Palmitic Acid / Q000378:metabolism; D010743:Phospholipids / Q000096:biosynthesis; D051381:Rats; D017208:Rats, Wistar; D046509:Tissue Culture Techniques; D014280:Triglycerides / Q000096:biosynthesis
chemical_list: D000085:Acetates; D000893:Anti-Inflammatory Agents; D007657:Ketone Bodies; D008055:Lipids; D010743:Phospholipids; D014280:Triglycerides; D019308:Palmitic Acid; D002784:Cholesterol; D005682:Gadolinium; D015232:Dinoprostone; C038958:gadolinium chloride; D005998:Glycine